Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies

Abstract Background Hyperimmune convalescent COVID-19 plasma (CCP) containing anti-SARS-CoV-2 neutralizing antibodies (NAbs) was proposed as a therapeutic option for patients early in the new coronavirus disease pandemic. The efficacy of this therapy depends on the quantity of neutralizing antibodie...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Katerina Jazbec, Mojca Jež, Klemen Žiberna, Polonca Mali, Živa Ramšak, Urška Rahne Potokar, Zdravko Kvrzić, Maja Černilec, Melita Gracar, Marjana Šprohar, Petra Jovanovič, Sonja Vuletić, Primož Rožman
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2023-03-01
Serie:	Virology Journal
Soggetti:	COVID-19 convalescent plasma Anti-SARS-CoV-2 antibodies Neutralization assay Antibody titer Hyperimmune plasma donors
Accesso online:	https://doi.org/10.1186/s12985-023-02007-0
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!